Important state and national stories, market and business news, sports and entertainment, delivered in quick-hit fashion ...
That's Gazyva in SLE, [indiscernible], the fenebrutinib data in PPMS. For several Phase ... And in SatraGo-2, there was a 53% versus 23% with a larger treatment effect. As a result, SatraGo-2 was able ...
How can imaging biomarkers enhance our understanding of MS? Dr Anne Cross and Dr Matthew Brier examine MRI advancements that provide new insights into diagnosis, progression, and treatment.
The MFN pricing approach, while politically attractive, raises complex questions about how to fairly and sustainably price ...
Objective Peer mentoring has been shown to be an effective intervention for chronic conditions with evidence to suggest that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback